USA Nuclear Medicine and Radiopharmaceuticals Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Nuclear Medicine and Radiopharmaceuticals market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Nuclear Medicine and Radiopharmaceuticals market. Detailed analysis of key players, along with key growth strategies adopted by Nuclear Medicine and Radiopharmaceuticals industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Lantheus

    • Mallinckrodt

    • Advanced Accelerator Applications

    • GE Healthcare

    • Triad Isotopes

    • IBA Group

    • Bayer

    • Dongcheng

    • Nordion

    • Jubilant Pharma

    • Eli Lilly

    • Bracco Imaging

    • Navidea

    • SIEMENS

    • China Isotope & Radiation

    By Type:

    • Diagnostic Radioisotopes

    • Therapeutic Radioisotopes

    By End-User:

    • Oncology

    • Cardiology

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine and Radiopharmaceuticals Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Radioisotopes from 2016 to 2027

      • 1.3.2 USA Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Radioisotopes from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2016 to 2027

      • 1.4.2 USA Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2016 to 2027

      • 1.4.3 USA Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Nuclear Medicine and Radiopharmaceuticals Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine and Radiopharmaceuticals by Major Types

      • 3.4.1 Market Size and Growth Rate of Diagnostic Radioisotopes

      • 3.4.2 Market Size and Growth Rate of Therapeutic Radioisotopes

    4 Segmentation of Nuclear Medicine and Radiopharmaceuticals Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine and Radiopharmaceuticals by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Nuclear Medicine and Radiopharmaceuticals in Oncology

      • 4.4.2 Market Size and Growth Rate of Nuclear Medicine and Radiopharmaceuticals in Cardiology

      • 4.4.3 Market Size and Growth Rate of Nuclear Medicine and Radiopharmaceuticals in Other

    5 Market Analysis by Regions

    • 5.1 USA Nuclear Medicine and Radiopharmaceuticals Production Analysis by Regions

    • 5.2 USA Nuclear Medicine and Radiopharmaceuticals Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis

    • 6.1 West USA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Major Types

    • 6.2 West USA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Major End-Users

    7 South USA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis

    • 7.1 South USA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Major Types

    • 7.2 South USA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Major End-Users

    8 Middle West USA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis

    • 8.1 Middle West USA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Major Types

    • 8.2 Middle West USA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Major End-Users

    9 Northeast USA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis

    • 9.1 Northeast USA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Major Types

    • 9.2 Northeast USA Nuclear Medicine and Radiopharmaceuticals Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Lantheus

        • 10.1.1 Lantheus Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Mallinckrodt

        • 10.2.1 Mallinckrodt Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Advanced Accelerator Applications

        • 10.3.1 Advanced Accelerator Applications Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 GE Healthcare

        • 10.4.1 GE Healthcare Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Triad Isotopes

        • 10.5.1 Triad Isotopes Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 IBA Group

        • 10.6.1 IBA Group Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Bayer

        • 10.7.1 Bayer Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Dongcheng

        • 10.8.1 Dongcheng Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Nordion

        • 10.9.1 Nordion Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Jubilant Pharma

        • 10.10.1 Jubilant Pharma Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Eli Lilly

        • 10.11.1 Eli Lilly Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Bracco Imaging

        • 10.12.1 Bracco Imaging Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Navidea

        • 10.13.1 Navidea Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 SIEMENS

        • 10.14.1 SIEMENS Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 China Isotope & Radiation

        • 10.15.1 China Isotope & Radiation Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Radioisotopes from 2016 to 2027

    • Figure USA Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Radioisotopes from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Oncology from 2016 to 2027

    • Figure USA Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Cardiology from 2016 to 2027

    • Figure USA Nuclear Medicine and Radiopharmaceuticals Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Nuclear Medicine and Radiopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine and Radiopharmaceuticals Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Nuclear Medicine and Radiopharmaceuticals

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine and Radiopharmaceuticals by Different Types from 2016 to 2027

    • Table Consumption Share of Nuclear Medicine and Radiopharmaceuticals by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Diagnostic Radioisotopes

    • Figure Market Size and Growth Rate of Therapeutic Radioisotopes

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Nuclear Medicine and Radiopharmaceuticals by Different End-Users from 2016 to 2027

    • Table Consumption Share of Nuclear Medicine and Radiopharmaceuticals by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Other

    • Table USA Nuclear Medicine and Radiopharmaceuticals Production by Regions

    • Table USA Nuclear Medicine and Radiopharmaceuticals Production Share by Regions

    • Figure USA Nuclear Medicine and Radiopharmaceuticals Production Share by Regions in 2016

    • Figure USA Nuclear Medicine and Radiopharmaceuticals Production Share by Regions in 2021

    • Figure USA Nuclear Medicine and Radiopharmaceuticals Production Share by Regions in 2027

    • Table USA Nuclear Medicine and Radiopharmaceuticals Consumption by Regions

    • Table USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Regions

    • Figure USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Regions in 2016

    • Figure USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Regions in 2021

    • Figure USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Regions in 2027

    • Table West USA Nuclear Medicine and Radiopharmaceuticals Consumption by Types from 2016 to 2027

    • Table West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types in 2016

    • Figure West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types in 2021

    • Figure West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types in 2027

    • Table West USA Nuclear Medicine and Radiopharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users in 2016

    • Figure West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users in 2021

    • Figure West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users in 2027

    • Table South USA Nuclear Medicine and Radiopharmaceuticals Consumption by Types from 2016 to 2027

    • Table South USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure South USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types in 2016

    • Figure South USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types in 2021

    • Figure South USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types in 2027

    • Table South USA Nuclear Medicine and Radiopharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table South USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users in 2016

    • Figure South USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users in 2021

    • Figure South USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users in 2027

    • Table Middle West USA Nuclear Medicine and Radiopharmaceuticals Consumption by Types from 2016 to 2027

    • Table Middle West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types in 2016

    • Figure Middle West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types in 2021

    • Figure Middle West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types in 2027

    • Table Middle West USA Nuclear Medicine and Radiopharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users in 2016

    • Figure Middle West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users in 2021

    • Figure Middle West USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users in 2027

    • Table Northeast USA Nuclear Medicine and Radiopharmaceuticals Consumption by Types from 2016 to 2027

    • Table Northeast USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types in 2016

    • Figure Northeast USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types in 2021

    • Figure Northeast USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by Types in 2027

    • Table Northeast USA Nuclear Medicine and Radiopharmaceuticals Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users in 2016

    • Figure Northeast USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users in 2021

    • Figure Northeast USA Nuclear Medicine and Radiopharmaceuticals Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Lantheus

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus

    • Figure Sales and Growth Rate Analysis of Lantheus

    • Figure Revenue and Market Share Analysis of Lantheus

    • Table Product and Service Introduction of Lantheus

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of Advanced Accelerator Applications

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Accelerator Applications

    • Figure Sales and Growth Rate Analysis of Advanced Accelerator Applications

    • Figure Revenue and Market Share Analysis of Advanced Accelerator Applications

    • Table Product and Service Introduction of Advanced Accelerator Applications

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of Triad Isotopes

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes

    • Figure Sales and Growth Rate Analysis of Triad Isotopes

    • Figure Revenue and Market Share Analysis of Triad Isotopes

    • Table Product and Service Introduction of Triad Isotopes

    • Table Company Profile and Development Status of IBA Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Group

    • Figure Sales and Growth Rate Analysis of IBA Group

    • Figure Revenue and Market Share Analysis of IBA Group

    • Table Product and Service Introduction of IBA Group

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Dongcheng

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dongcheng

    • Figure Sales and Growth Rate Analysis of Dongcheng

    • Figure Revenue and Market Share Analysis of Dongcheng

    • Table Product and Service Introduction of Dongcheng

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of Jubilant Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma

    • Figure Sales and Growth Rate Analysis of Jubilant Pharma

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Product and Service Introduction of Jubilant Pharma

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Bracco Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bracco Imaging

    • Figure Sales and Growth Rate Analysis of Bracco Imaging

    • Figure Revenue and Market Share Analysis of Bracco Imaging

    • Table Product and Service Introduction of Bracco Imaging

    • Table Company Profile and Development Status of Navidea

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Navidea

    • Figure Sales and Growth Rate Analysis of Navidea

    • Figure Revenue and Market Share Analysis of Navidea

    • Table Product and Service Introduction of Navidea

    • Table Company Profile and Development Status of SIEMENS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIEMENS

    • Figure Sales and Growth Rate Analysis of SIEMENS

    • Figure Revenue and Market Share Analysis of SIEMENS

    • Table Product and Service Introduction of SIEMENS

    • Table Company Profile and Development Status of China Isotope & Radiation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Isotope & Radiation

    • Figure Sales and Growth Rate Analysis of China Isotope & Radiation

    • Figure Revenue and Market Share Analysis of China Isotope & Radiation

    • Table Product and Service Introduction of China Isotope & Radiation


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.